Introduction
Before 1988, hybridization with nucleic acid probes was the only available nucleic acid-based technique for the detection and diagnosis of infectious agents. Since 1988, the widespread ivailability of the polymerase chain reaction (PCR) has offered a rapid and sensitive alternative. Has PCR completely superseded probing technology or is there room for both methods in today's diagnostics? This article discusses the relative advantages and disadvantages of both methods and argues that there is still a role for both in the detection and diagnosis of disease.
In order to allow a discussion in depth of the technologies, a basic knowledge of the principles of nucleic acid hybridization and of PCR will be assumed. Those wishing to refresh their memories of these techniques can find excellent books on the subject (KELLER & MANAK, 1989; KRICKA, 1992; PERSING et al., 1993) .
Application of nucleic acid probes
Fragments of deoxyribonucleic acid (DNA) have been cloned and sequenced from almost every conceivable human pathogen. By carefully selecting those fragments which have a species-specific sequence it is possible to generate specific probes for any human pathogen. However, specificity is not the only desirable attribute of a useful probe; they must also be sensitive, especially when used for patient diagnosis when the infectious agent is dispersed in the infected tissue. Most sensitive probes have been developed by targeting either multicopy seauences such as ribosomal ribonucleic acid (RNA) sequences or genomic or extra-chromosomal repeats.. For example, probes have been developed against the ribosomal RNAs of malaria, against the extra-chromosomal kinetoplast DNAs of Lkisi;mania, and against the genomic reneats of both Leishmania and malaria (BARKER, 1989) . Although when used at optimum efficiency on cultured material such probes can recognize as few as 100 parasites in infected material, the sensitivity is probably at least ten-fold lower.
In the late 1980s there was much optimism at the potential of DNA probes. This is reflected in the rise in number of publications on the subject throughout 1987-1989. However, very few of these numerous publications resulted in applications for general use and no DNA probe is in widespread use in the general diagnostic laboratory. Many commercially available DNA probe kits are not for direct detection in infected tissue but are intended for use with cultured organisms as an aid to a more rapid or definitive culture confirmation. There are exceptions to this, for example chemiluminescent solution hybridization tests are commercially available for gonorrhoea and chlamydia and for some viral infections including he atitis B, human papillomavirus and human immunode iciency virus type 1. The success of the F. probes for chlamydia and gonorrhoea can be explained in part by the low sensitivity of culture, which is the current 'gold standard'. Despite these exceptions, the interest in DNA probes for diagnosis or detection of disease has shown signs of waning. -
The main stumbling block was once perceived to be the reliance on radioactive labelling of the probes for maximum sensitivity. The radioisotope commonly used, 32P, has a short half-life and cannot be incoruorated into kits with a reasonable shelf life. Alternative non-radioactive labels such as biotin and digoxigenin detected with streptavidin or antibody conjugates did become available but the sensitivity of these systems when used with colorimetric substrates was at least ten-fold lower than that of radioactivity. So, although the use of DNA probes as research tools continued to blossom, their use in detection of diagnosis of disease was limited.
Chemiluminescent substrates for use in conjugation with DNA probes first became commercially available in [1989] [1990] . Some of these, particularlv the dioxetanebased substrates for use in conjunction-with membranebased detection formats involving alkaline phosphatase, have proved to be as sensitive as radioactivity and are more rapid. A signal which might develop overnight in a radioactive format is generated in only 3 h in a chemiluminescent system. However, the chemiluminescent detection protocol, when used with enzyme conjugates, is not as convenient as radioactivity, with an increased number of steps and 'hands-on' time. To some extent, though, direct linking of enzyme reporter molecules to the DNA probe can overcome these disadvantages.
The advent of chemiluminescent substrates produced a rash of publications as authors adapted their existing detection formats to chemiluminescence, but their arrival also coincided with the invention of amplification technologies. The latter were quickly perceived as sensitive rapid methods which were adopted in preference to probing technologies which, after the initial excitement of chemiluminescence, have continued to decline.
This short history of DNA probes can be illustrated by referring to the history of the development of DNA probes for malaria. The more sensitive probes were directed against either ribosomal RNA sequences or the 21 base pa& repeat sequence which occurs thousands of times in the aenome of Plasmodium falciDarum. The first probes against these targets were labelled with radioactivity. These probes were exhaustively evaluated for field use and were found to be, at best, comparable to microscopy for the detection of malaria (LANAR et al., 1989) . With the advent of chemiluminescence these probes were reevaluated, both in comparison to similar probes labelled with radioactivity and, once again, to microscopy.
Desnite all this work on DNA probes, microscow remains *the method of choice for -diagnosis in the-field. Why is this? It is because DNA probe technology involves a whole new level of complexity with no gain in sensitivity or specificity. A simple membrane-based chemiluminescent probing protocol from sample preparation to result may involve as many as 15 different steps (10 for radioactive and enzyme-labelled probes) carried out over 24 h, with each step requiring different solutions and different pieces of equipment such as water baths, ovens, slot-blotters, bag sealers, autoradiography cassettes etc. Although the procedures at each step are not complicated, in all it is a lengthy procedure requiring training and sustained concentration for optimum results.
Despite these limitations it is unlikely that the use of DNA nrobes for diaenosis will become extinct. There are niches-to which probes are well suited, particularly when conventional methods of diagnosis are inadequate. For example, culture is used for the detection of chlamvdia and gonorrhoea but is not ideal. Further important roles for DNA probes include hybridization in situ for species confirmation after culture or for use in large scale epi-demiological screening when hundreds or perhaps even thousands of samples can be fixed to a membrane and processed simultaneously at low cost. It has been estimated that the reagent cost for chemiluminescent membrane-based hybridization can be less than 10 pence $0. 10) per sample if 100 samples are processed simultaneouslv. A comparative techniaue-for examnle, microscopyiwould be extremely tedous on such a large scale. Similarlv. if vectors of disease such as sandflies or mosquitoes *&e being screened, sensitivity is maintained because the parasites are amplified and concentrated within the vector.
If DNA probes are to be useful even in these welldefined niches. it is essential that thev should be readilv available. Yet 'there is not one commercially available probe for a tropical disease. The reason is one of economics. The demand for any one probe is likely to be limited. This, coupled to the tropical emphasis, means that there is no money to be made in this field. One way around this is to consider the collective demand for DNA g robes. The demand for any one probe might be small ut if a bank of tronical disease DNA nrobes were established the collective demand could be high. If each probe were designed to be used with the same basic detection format, a chemiluminescent detection svstem for example, then it would be easy to supply the generic detection kit with the specific probe requested. Such a bank of probes could promote the use of probe technology as a research tool in the tropics.
Application of the polymerase chain reaction
Conceived in 1985 and made practicable by the introduction of a thermostable polymerase in 1988, PCR technologv has undergone a boom and become an invaluable tool & the research laboratory. Once again, mirroring the plight of DNA probes, there was much optimism that this technology would revolutionize diagnostics. And, similarly, in recent years this optimism waned as practi: cal problems of application came to the fore. The most significant problems of the method were its complexity, unreliability and cost.
Although PCR is intrinsically sensitive, its sensitivity in clinical detection depends on the amount of samnle which can be added to-the reaction without causing inhibition. For examnle, more than l/uL of blood added to a 100 uL reaction-causes complete' inhibition. Samples therefore must be concentrated and freed of inhibitors for maximum sensitivity and the sample preparation methods employed are often complex. For maximum sensitivity and specificity reactions are often performed in 2 steps (so-called 'nesting') which increases costs and manipulations. PCR products are commonly analysed by agarose gel electrophoresis or hybridization. The former method is not conducive to large-scale routine analysis and the latter involves a whole new level of complexity and cost. Now, to a large extent, these problems have been addressed. Reagents for simple sample preparation even from blood are commercially available. Nesting, if required, can be done automatically within the same reaction and the PCR products can be detected colorimetritally on microtitre plates. Similarly, post-PCR hybridizations can be nerformed raoidlv and eflicientlv in solution and the hybiids formed can be captured and-detected on microtitre plates or magnetic beads, for example. Once time and effort has been invested in adapting a given PCR assay to a simplified format, the test is not complex and involves few manipulations.
PCR may not be reliable for diagosis because of the possibility of contamination (KWOK & HIGUCHI, 1989) . DNA which has been amplified by PCR is released into the laboratory environment, probably as invisible microaerosols formed as tubes are onened and closed. With time this DNA builds up in the environment, coating floors and walls and borne through the air on dust particles. Laboratory workers pick up this DNA on hair, clothes or lingers. If even a few molecules of this DNA manage to get into a new amplification reaction they will be further amplified and a negative reaction will become positive. This-gives rise to false positive reactions and can lead to misdiarmosis. To illustrate the scale of the Droblem, one drop of product from a PCR reaction mixed with the water filling an Olympic-size swimming pool could be reamnlified bv a subsequent PCR, even after such a homeopathic dilution. Expensive kits are available which snecificallv demade nreviouslv amnlified DNA. so removing any conta&at<ng DNA-from new reactions (THORNTON et al., 1992) , but I have found these to be unnecessary. To a large extent contamination can be controlled by separating work areas so that reactions are prepared in a different room and with different equipment from those involved with product analysis.
PCR is often thought of as expensive, but after an initial outlay of about &3000-&7000 for a thermal cycler (the range of prices reflects the range of machines available) the basic cost per test for reagents for sample preparation, the reaction and analysis of product can be as little as 50 pence (&O.SO). The real cost is for the licence agreement from La Roche, which is needed if the test is to be offered commercially. At present PCR kits are available commercially for the detection of tuberculosis and chlamydia and the test for the latter is more sensitive than culture and DNA hybridization.
PCR is usually not very rapid with the most sensitive, including sampie preparation and product analysis, taking 24 h (or as long as 48 h for some methods which analyie product by membrane-based hybridization). This time can be reduced, if fast capillary machines are used, to one working day. If one machine is being used a run usually involves a maximum of 47 reactions in microtubes (one position being occupied by the thermocouple), or 96 reactions on a microtitre plate. If samples are analysed in duplicate, this halves the number of samples which can be assayed per run-and this does not take into account positive or negative controls. Sample preparation also limits the number of samples which can be assayed simultaneously. One or more centrifugation steps are employed in most sample preparation protocols and, as most centrifuges hold a maximum of 12 tubes, this becomes limiting. One way around these 'bottle-necks' is to mix a number of samples and assay them as a pool. This technique may find a use in studies looking for malarial parasites in mosquito vectors, for example.
One important application of PCR is in the detection of drug resistance. For example, the genetic basis of the resistance of malarial parasites to pyrimethamine has been elucidated (WELLEMS, 1991) . Resistance is defined by a localized specific mutation in the dihydrofolate reductase gene which can be identified bv PCR. This assay can be performed on samples without culturing, and the result can be available within a dav. This has immediate implications for determining therapy regimes. Chloroquine is an important antimalarial drug but the mechanism of resistance to it is yet to be determined. It would be lucky if one defined mutation were responsible, but this is rarely the case. Often several distinct mutations can result in the same phenotypic expression. Even pyrimethamine resistance is not as straightforward as might first appear because, although there is one major mutation responsible for the development of resistance, the degree of resistance is governed by several loci. So, to gain an accurate profile of resistance, several PCRs would have to be performed, each with different sets of primers, and this would be impractical for large numbers of samples.
Other amplification technologies have been developed and these include the ligase chain reaction (LCR), the Qp replicase system, the self-sustained sequence replication (3SR) and nucleic acid seauence-based amnlification (NAS~A) . 'A kit for the rapid and sensitive detection of tuberculosis based on 3SR is soon to be marketed by GenProbe but at a cost of about US $30 per test it is likely to be some time before this is used in the tropics. This cost, however, compares favourably to that of PCR because, although the actual cost of a PCR kit if purchased from La Roche is less, a licence is needed if the kit is to be used commercially and this adds to the cost. No licence is required for use of the GenProbe system. Nucleic acid probes versus PCR DNA hybridization is, on the whole, insensitive and repeated elements within organisms must be targeted for maximum sensitivity. It is a relatively cheap technique, however, and in membrane-based systems allows hundreds or even thousands of samples to be screened simultaneously, which is useful for epidemiological studies.
PCR is a much more expensive technique, particularly if the reagents are not assembled in-house and expensive hits have to be purchased. It need not be complex but is not easily applied to large scale screening. The technique can be very sensitive, but that sensitivity is dependent on adequate sample preparation. PCR is the preferred technique when sensitivity is the overriding requirement and is particular1 the future P e suited to individual patient diagnosis. In R is also likely to find increasing application in the rapid detection of drug resistance.
